Brock Lesnar's WWE slate is full (relatively speaking), and he wants more time before his upcoming hearing regarding his failed USADA tests.
Lesnar's legal team has requested a continuance for his Nevada Athletic Commission hearing, per Brett Okamoto. Lesnar was set for a November 10 NAC hearing, but his team wanted additional time to test a foot cream they believe may have been the cause of the failure.
Lesnar failed an out-of-competition test on June 28, and a UFC 200 post-fight drug test July 9 — both for clomiphene.
See Also: Exclusive: Daniel Cormier On The Summerslam Finish And What Brock Lesnar Is Really Good At
Estrogen blockers such as clomiphene are typically used when reducing the amount of estrogen your body produces and to stimulate natural testosterone production after the use of anabolic steroids. They're also often used when trying to prevent testosterone turning into estrogen.
According to MMA Fighting, Lesnar had the cream tested at a WADA-accredited lab in Salt Lake City. An eye medication was also tested, but showed no traces of clomiphene. Lesnar could see his unanimous decision victory over Mark Hunt overturned to a no-contest.
Despite Lesnar asking for his continuance, the NAC plans to hold disciplinary hearings on November 10 for Jon Jones in relation to his failed drug tests, as well as Nate Diaz for his part in a water bottle throwing incident ahead of UFC 202.
Lesnar will face Bill Goldberg at WWE Survivor Series on November 20, and Rusev at a WWE live event in December.
